Current and future applications of biomarkers in samples collected through minimally invasive methods for cancer medicine and population‐based research
Bibliographic Data
| ID | 19459494 |
|---|---|
| Authors | Alicia M Delouize (0000-0002-9045-6428, Department of Anthropology University of Oregon Eugene Oregon USA, corresponding author), Geeta N Eick (0000-0001-7512-3265, Department of Anthropology University of Oregon Eugene Oregon USA), Sana D Karam (0000-0003-1676-5967, Department of Radiation Oncology University of Colorado School of Medicine Aurora Colorado USA), Jeffrey Snodgra (0000-0002-7021-777X, Department of Anthropology University of Oregon Eugene Oregon USA) |
| Year | 2022 |
| Volume | 34 |
| Issue | 11 |
| Pages | e23665-e23665 |
| Publication date | 2022-11-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | American Journal of Human Biology (JOURNAL) |
| Journal identifiers | ISSN: 1042-0533 • E-ISSN: 1520-6300 |
| Publisher | Wiley (PUBLISHER • GB) |
| DOI | 10.1002/ajhb.23665 |
| PMID | 34374148 |
| OpenAlex | W3191624094 |
| Language | EN |
| Citations received | 2 |
| References cited | 189 |
Despite advances in cancer medicine and research, invasive and potentially risky procedures such as biopsies, venous blood tests, imaging, colonoscopy, and pap smear tests are still primarily used for screening, staging, and assessing response to therapy. The development and interdisciplinary use of biomarkers from urine, feces, saliva, scent, and capillary blood collected with minimally invasive methods represents a potential opportunity for integration with biomarker analysis for cancers, both in clinical practice (e.g., in screening, treatment, and disease monitoring, and improved quality of life for patients) and population‐based research (e.g., in epidemiology/public health, studies of social and environmental determinants, and evolutionary medicine). In this article, we review the scientific rationale, benefits, challenges, and potential opportunities for measuring cancer‐related biomarkers in samples collected through minimally invasive methods
Biology · Biomarker · Cancer · Environmental health · Intensive care medicine · Pathology · Population · Colorectal Cancer Screening and Detection · Medicine · Metabolomics and Mass Spectrometry Studies · Molecular Biology Techniques and Applications · Internal Medicine
Evolutionary Medicine
Social Determinants of Health
Causes of cancer in the world
Influence of Socioeconomic and Cultural Factors on Racial Differences in Late-Stage Presentation of Breast Cancer
Socio-economic status over the life course and obesity
Pleiotropy, Natural Selection, and the Evolution of Senescence
The health gap
Covid-19 and the impact of social determinants of health
Oxford Handbook of Evolutionary Medicine
A dried blood spot‐based method to measure levels of tartrate‐resistant acid phosphatase 5b (TRACP‐5b), a marker of bone resorption
Development and validation of assay protocols for use with dried blood spot samples
Telomere length analysis from minimally‐invasively collected samples
Digit ratio (2D
A highly sensitive multiplex immunoassay for inflammatory cytokines in dried blood spots
Reproductive hormone measurement from minimally invasive sample types
The Tsimane Health and Life History Project
Immune function in Amazonian horticulturalists
What a drop can do
Validation of an Optimized Elisa for Quantitative Assessment of Epstein-Barr Virus Antibodies from Dried Blood Spots
Enzyme-Linked Immunoassay-Based Quantitative Measurement of Apolipoprotein B (ApoB) in Dried Blood Spots, a Biomarker of Cardiovascular Disease Risk
Development and validation of an Elisa for a biomarker of thyroid dysfunction, thyroid peroxidase autoantibodies (TPO-Ab), in dried blood spots
Taking the Lab to the Field
| Unique citing works | 2 |
|---|---|
| Citations per year | 0,5 |
| Citation span | 2022 - 2022 (1) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 2 |